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ABSTRACT
Objective: We performed a systematic review, meta-
analysis and assessed the evidence supporting a
causal link between knee joint loading during walking
and structural knee osteoarthritis (OA) progression.
Design: Systematic review, meta-analysis and
application of Bradford Hill’s considerations on
causation.
Data sources: We searched MEDLINE, Scopus,
AMED, CINAHL and SportsDiscus for prospective
cohort studies and randomised controlled trials (RCTs)
from 1950 through October 2013.
Study eligibility criteria: We selected cohort studies
and RCTs in which estimates of knee joint loading
during walking were used to predict structural knee OA
progression assessed by X-ray or MRI.
Data analyses: Meta-analysis was performed to
estimate the combined OR for structural disease
progression with higher baseline loading. The
likelihood of a causal link between knee joint loading
and OA progression was assessed from cohort studies
using the Bradford Hill guidelines to derive a 0–4
causation score based on four criteria and examined
for confirmation in RCTs.
Results: Of the 1078 potentially eligible articles, 5
prospective cohort studies were included. The studies
included a total of 452 patients relating joint loading to
disease progression over 12–72 months. There were
very serious limitations associated with the
methodological quality of the included studies. The
combined OR for disease progression was 1.90 (95%
CI 0.85 to 4.25; I2=77%) for each one-unit increment
in baseline knee loading. The combined causation
score was 0, indicating no causal association between
knee loading and knee OA progression. No RCTs were
found to confirm or refute the findings from the cohort
studies.
Conclusions: There is very limited and low-quality
evidence to support for a causal link between knee
joint loading during walking and structural progression
of knee OA.
Trial registration number: CRD42012003253
BACKGROUND
Osteoarthritis (OA) is the most common
form of arthritis affecting a large section of
the population, and is a major cause of
illness and disability.1 2 The knee joint is
most frequently affected,3 and due to the
knee’s crucial role in independent ambula-
tion, knee OA leads to considerable disability
affecting an individual’s participation in
society and independent living. Because no
cure is available and many people are
affected, healthcare costs associated with
knee OA are enormous—even higher than
for the more high-proﬁle diseases such as
diabetes, cancer and cardiovascular diseases.4
With its prevalence on the rise, knee OA
poses a substantial socioeconomic and public
health burden.
Walking is the most common form of
human locomotion, and most people walk
every day, resulting in millions of steps per
year. Biomechanical loading on the knee
joint during walking is estimated to exceed
2–3 times body weight5; thus, knee joint
loading is unavoidable component of an
Strengths and limitations of this study
▪ We performed the first systematic evaluation of
the evidence for a causal link between mechan-
ical loading of the knee during walking and
structural progression of knee osteoarthritis.
▪ This systematic review, meta-analysis, and caus-
ation analysis find very limited evidence of a
causal link between knee joint loading during
walking and structural progression of knee
osteoarthritis.
▪ Few studies were included in the meta-analysis
since only a small number of studies have been
conducted. Further research is needed.
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independent lifestyle. One widely accepted theory is that
higher knee joint loading during walking is causally
linked with accelerated structural knee OA progres-
sion.6–8 In accordance with this theory, unloading is
advocated in an attempt to slow or halt disease progres-
sion.9 Unspeciﬁc measures of high joint loading, such as
excess body mass and body mass index (BMI), have
been associated with OA development,10 11 and obesity
is believed to act mainly through high mechanical
loads,12 although systemic effects have also been indi-
cated.13 However, higher body mass does not necessarily
lead to higher joint loading during walking,14 and more
speciﬁc measures of joint loading are necessary to apply.
Objective estimates of joint loading during walking
can be obtained by three-dimensional gait analysis.
Typically, the knee adduction moment (KAM) or bio-
mechanical modelling of compression forces is used.
The KAM has been of particular interest because it
reﬂects the medial to lateral joint load distribution,15
with good face validity with respect to the relative preva-
lence of medial, as opposed to lateral compartment,
tibiofemoral knee OA.16 Despite its common usage, a
recent systematic review did not ﬁnd consistent evidence
to the fact that the KAM differs between those with and
without knee OA.17
The relationship between knee joint loading during
walking and knee OA has been a focus of knee
OA-related biomechanical research for 10–20 years.
Studies reveal that symptomatic treatment of knee OA
results in increases in knee joint loads during
walking,5 18–20 which are unwanted according to the
hypothesised structural consequences of increased joint
loading. This may generate confusion among research-
ers, clinicians and patients, who are interested in this
information to aid them in prevention, palliation and
treatment strategies. Establishing causal relationship
among modiﬁable factors, such as knee joint loading,
and disease-speciﬁc measures, such as structural disease
progression, is imperative in the generation of effective
strategies.
Seminal epidemiological work by Hill proposed a set
of considerations (the Bradford Hill criteria) to systemat-
ically evaluate the existence of a causal link between an
exposure and a health outcome.21 These criteria have
been previously employed to demonstrate the causal
link between smoking and lung cancer,22 and between
dietary factors and coronary heart disease,23 and have
the capacity to evaluate the link between knee joint
loading and structural knee OA progression.
Therefore, the objectives of this study were (1) to sys-
tematically evaluate the evidence supporting a causal
link between exposure to knee joint loading during
walking and structural progression of knee OA based on
Hill’s considerations on causality21 and (2) to determine
which knee joint load variables had been studied sufﬁ-
ciently in randomised controlled trials (RCTs) and
found to support the ﬁndings of prospective cohort
studies.
METHODS
The methods of the study search strategy, inclusion cri-
teria and data analysis were prespeciﬁed in a protocol
(see online supplementary ﬁle 1) and pre-registered
(PROSPERO 2012:CRD42012003253).
We searched MEDLINE, Scopus, AMED, CINAHL and
SportsDiscus for prospective cohort studies and RCTs
from 1950 through October 2013. Search strategies are
available as an online supplementary ﬁle 2. The refer-
ence lists of the retrieved articles were also searched for
additional cohort studies and RCTs. Two reviewers (MH
and MWC) independently assessed study eligibility.
Excluded studies and reasons for exclusion were
recorded. Disagreement was resolved by discussion and
consensus. We included original full-length articles per-
taining to the association between knee joint loading
during walking, measured by three-dimensional gait ana-
lysis, and structural disease progression assessed quanti-
tatively or semiquantitatively by X-ray or MRI. We
considered only those studies that included participants
diagnosed with knee OA that were followed for at least
1 year (necessarily because of the sensitivity of imaging
and slow disease progression24). Cohort studies had to
include estimates of knee joint loading during walking
at baseline and imaging-based assessment of structural
disease progression. Clinical trials had to be randomised
and compare image-based structural disease progression
among different knee joint loading interventions
(eg, increase vs decrease), placebo or control.
Data extraction and analysis
The following data were extracted from the studies: (1)
Study design; (2) Country of origin; (3) Number of sub-
jects; (4) Characteristics of the subjects; (5) Type of
knee joint loading estimate; (6) Magnitudes of the esti-
mate; (7) Description of the interventions (if any) and
(8) Structural disease progression outcome (ie, semi-
quantitative or quantitative measures on X-ray and/or
MRI).
For prospective cohort studies, we extracted estimates
of the association between baseline knee joint loading
and structural disease progression from baseline to
follow-up. A progression group is typically compared to a
non-progression group at baseline and the results are
typically reported as ORs for disease progression for a
one-unit higher baseline knee joint loading. If no OR
was reported, we either calculated it from the reported
data (if possible), or contacted the study authors and
requested for the OR. For the RCTs we aimed to
compare relative risks of structural disease progression
between knee joint loading modiﬁcation and control
groups.
The individual study results (ie, log OR values and
their corresponding SEs) were combined in a random
effects meta-analysis model using the generic inverse
variance outcome type in Review Manager.25
Heterogeneity between trials was assessed using the
standard Q-test statistic (testing the hypothesis of
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homogeneity), and we present the I2 value, which can
be interpreted as the percentage of total variation across
the studies due to heterogeneity.26
Methodological quality and risk of bias assessment
The methodological quality of the cohort studies was
assessed using a published check list.27 Two of the
authors (MH and MWC) assessed this individually and
judged each criterion to be ‘Adequately described’,
‘Unclear’, or ‘Inadequately described’–corresponding to
‘low risk of bias’, ‘unclear risk of bias’, and ‘high risk of
bias’, respectively. Disagreement was resolved by discus-
sion. If an included study was authored by one or more
of the current authors, a third reviewer (HL) was asked
to perform a quality assessment. One quality assessment
item was omitted (“Was a dose–response relationship
between exposure and outcome demonstrated?”)
because this item relates to the ﬁndings of the study and
not the methodological quality, and assessment of dose–
response forms part of the Bradford Hill criteria for
causation (see below). The overall extent of risk of bias
and methodological quality within each study was
assessed using the GRADE approach to evaluate study
limitations.28
Evaluation of evidence for causality
Based on the Bradford Hill considerations on causality,21
a causation score was developed and used to systematic-
ally evaluate the evidence of a causal link between knee
joint loading during walking and structural progression
of knee OA. A similar score has previously been derived
from the Bradford Hill considerations to assess the
causal relationship between dietary factors and coronary
heart disease.23 The following criteria were used in the
review of the cohort studies and given a score of 1 (cri-
terion satisﬁed) or 0 (criterion not satisﬁed):
1. Strength of association: Associations quantiﬁed as a
pooled OR ≥5.0, with lower 95% CI above 2.0; the
expected direction was deﬁned as ‘strong associ-
ation.’ ‘Moderate association’ is deﬁned as any statis-
tically signiﬁcant pooled OR (p<0.05). A statistically
non-signiﬁcant pooled OR was deﬁned as ‘no
association.’
2. Consistency across studies: An association requires repli-
cation in other studies. Consistency is deﬁned as
≥75% of associations being strong or moderate.
3. Temporality: Refers to temporal relationship of associ-
ation between exposure and outcome; exposure has
to precede outcome. It is difﬁcult to ensure temporal
correctness because study participants are assumed to
walk daily and are, therefore, exposed to knee joint
loading throughout observation periods. We retained
this criterion because temporality is necessary to
infer causation; absence of temporal relationship
between exposure and outcome precludes a causal
link. Our analysis accepted studies with a temporally
correct design deﬁned as baseline knee joint loading
related to disease progression over time from that
baseline. The temporality criterion was satisﬁed when
temporal correctness was accepted in ≥75% of the
included studies.
4. Biological gradient: When rate of progression increases
(or decreases) incrementally as dose of exposure
increases; provides strong evidence of causal relation-
ship. This criterion is satisﬁed when ≥75% of tests for
a trend pertaining to structural progression outcomes
are statistically signiﬁcant in the expected direction
for knee joint loading.
The aforementioned four criteria scores were applied
to derive one causation score for each knee joint
loading variable. The scores were computed as the
unweighted sum of the scores from each of the above
criteria, for a possible range of 0–4. A score of 4 is con-
sidered strong evidence of a cause-and-effect relation-
ship. A score of 3 is deemed to indicate moderate
evidence. A score of 2 or less is considered weak evi-
dence of causation.
A ﬁfth criterion, experimental evidence, was used to
examine whether the evidence from the prospective
cohort studies was consistent with that from RCTs.
Experimental evidence enhances the probability of caus-
ation, and may be used to upgrade or downgrade the
calculated causation score.
The following four criteria were omitted:
Coherence: Causation is more likely if what is observed
is supported by and in agreement with the natural
history of the disease. This criterion is usually applied
when the outcome is assessed by surrogate outcomes.
This criterion is omitted because it is satisﬁed by default
since imaging modalities are surrogate outcomes.
Plausibility relates to the assessment of whether the
association is plausible or not. This criterion is omitted
because of the highly subjective nature of this criterion.
Speciﬁcity relates to the speciﬁc response to the expos-
ure. This criterion is omitted because OA is a multistruc-
ture disease; an association between knee joint loading
and disease progression in multiple structures does not
preclude a possible causal relationship.
Analogy relates to the possibility that existing similar
association can support causation (eg, Does the same
association exist for hip or hand OA? If so, causation
may be supported). This criterion is omitted because
this review focuses speciﬁcally on knee OA.
RESULTS
Study selection and characteristics
The search yielded 1078 potentially eligible studies
(ﬁgure 1; references available in online supplementary
ﬁle 3). Of those, we included ﬁve prospective cohort
studies published between 2002 and 2013 and involving
a total of 452 patients with knee OA29–33 and 0 RCTs.
The diagnostic criteria for knee OA used to determine
participant inclusion in individual studies varied. The
American College of Rheumatology (ACR) criteria34
were used in one study,32 whereas a combination of
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clinical and radiographic signs of knee OA was used as
criteria in three studies,29 31 33 and one study did not
report the diagnostic criteria used.30 Study character-
istics are summarised in table 1.
Joint loading and structural progression measures
Four cohort studies29–32 focused on the same knee joint
loading estimate: the peak KAM. In these studies, peak
KAM was assessed at baseline and related to structural
medial disease progression assessed after a median of
15 months from that baseline (12–72 months). In one
study,29 the baseline KAM impulse (area under the
curve) was also related to medial disease progression. In
the ﬁfth study,33 overall knee compression loading was
used as load exposure.
Two studies30 31 deﬁned structural disease progression
as any worsening in semiquantitative radiographic
medial joint space grade.36 One study32 deﬁned struc-
tural disease progression as any loss of medial femoral
cartilage volume (quantitative MRI) above a measure-
ment error previously established. In another study,33
structural disease progression was assessed from semi-
quantitative grading of tibiofemoral cartilage loss and
bone marrow lesions. In one study,29 structural progres-
sion was assessed semi-quantitatively as medial tibiofe-
moral cartilage loss and medial tibiofemoral bone
marrow lesions, and quantitatively as medial tibial cartil-
age volume loss. For the meta-analysis, we extracted the
association (OR) between peak KAM and semiquantita-
tive progression in medial tibiofemoral cartilage loss. No
ORs were available for the association between KAM and
cartilage volume loss because both were continuous vari-
ables. However, the linear regression analysis was
extracted for the assessment of the biological gradient
criteria.
Association between joint loading and progression
ORs were not reported in three studies,31–33 but in32
individual patient data were reported and an OR was cal-
culated. We contacted the authors of ref. 31 asking them
to provide an OR if possible. The authors returned a
conference abstract including an OR published 4 years
prior to the article.35 The abstract recorded 64 patients
in contrast to the 57 patients included in ref. 31 The
authors could not account for the difference in number
of the subjects between the full paper and conference
abstract. One study33 grouped participants based on
changes in joint loading following weight loss (increased
vs reduced loads) and found no between group differ-
ences in structural disease progression. Owing to the use
of an intervention (weight loss), it was not appropriate
to extract OR for baseline loading.
The ORs for structural disease progression ranged
from 0.40 to 6.46 for each unit higher baseline peak
KAM magnitudes. From the random effects model, the
combined OR was estimated to 1.90 (95% CI 0.85 to
4.25). The conﬁdence in this estimate was downgraded
due to heterogeneity (I2=77%). Figure 2 summarises the
individual and pooled estimates.
In ref 29, the OR for progression of bone marrow
lesions was 1.31 (95% CI 0.86 to 1.98) with every unit
increment in baseline peak KAM; ORs for progression
of cartilage defects and bone marrow lesions were 0.42
(95% CI 0.12 to 1.48) and 1.8 (95% CI 0.63 to 5.17),
respectively, with every unit increment in baseline KAM
impulse.
Methodological quality of the studies
One or more criteria were limited in the assessments of
risk of selection, detection and attrition biases.
Individual risk assessments are presented in online
Figure 1 Flow chart of the literature selection process (OA, osteoarthritis; RCTs, randomised controlled trials).
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supplementary appendix A. Across the studies, the com-
parability of the groups at baseline was generally inad-
equately or unclearly described (selection bias). Also,
descriptions of how reliably the joint load exposures
were ascertained were not included in four of the ﬁve
studies (detection bias), and group differences in loss of
subjects were not accounted for (attrition bias). The dis-
crepancy in subject numbers in reports from one
cohort,31 35 induced a high risk of selection and attrition
bias. Table 2 presents summaries of the quality assess-
ment. Agreement between quality raters was good
(κ=0.73 (95% CI 0.48 to 0.97)).
Causality assessment
The non-signiﬁcant combined OR indicates no associ-
ation between knee joint load during walking and struc-
tural disease progression. Thus, a score of 0 in the
Strength of Association criterion was assigned. The
associations were not consistently replicated (50%),
resulting in a score of 0 in the Consistency criterion. This
ﬁnding was further supported by the heterogeneity
between the studies (I2=77%; ﬁgure 2), and the discrep-
ancies between baseline peak KAM magnitudes among
progressors and non-progressors across the cohorts
(ﬁgure 3). Temporal correctness was accepted in one
cohort.30 After requesting for additional information
from the authors of one cohort study,31 we discovered
that the article reported only part of the study. The add-
itional information retrieved35 showed that the study
consisted of three measurements taken every 18 months.
Joint space and Kellgren-Lawrence grades (X-rays) were
recorded at all three time points, whereas the KAM was
obtained at time points 2 and 3 (18 and 36 months).
KAM at time point 2 (18 months) was associated with
structural disease progression from 18 to 36 months and
structural disease progression from time points 1 to 2
Table 1 Summary of the characteristics of the included studies
Author
(year)
country
Knee loading
variable
Structural
progression measure
Follow-up
time
(months)
Number of patients
(total/progressors/
non-progressors)
Females
(%) Reference
Miyazaki
et al (2002)
Japan
Peak KAM (unit:
%BW×HT)
≥1 grade
according to
Altman atlas
sq
X-ray
72 74/42/32 78 30
Chang et al
(2007) USA
Peak KAM (unit:
%BW×HT)
≥1 grade
according to
Altman atlas
sq
X-ray
18 56 (64*)/41/15 59 31
35*
Bennell et al
(2011)
Australia
Peak KAM (unit:
%BW×HT)
≥1 grade
medial
tibiofemoral
cartilage
defects
sq
MRI
12 138/45/93 56 29
KAM impulse
(unit: %BW×HT)
Cartilage
volume loss
(mm3)
q
MRI
144/NA/NA
Woollard
et al (2011)
USA
Peak KAM (unit:
Nm/kg)†
Cartilage
volume loss
(mm3)
q
MRI
12 13/6/7 23 32
Henriksen
et al (2013)
Denmark
Peak overall
knee
compression
force (unit: N)
Cartilage loss sq
MRI
12 157/NA/NA 89 33
Median: 12 Totals: 452/134/147 Mean: 67
*On request, the authors forwarded a conference abstract with additional data based on 64 subjects. The number of progressors/
non-progressors was not available from that abstract.
†We converted the data into %BW×HT after requesting for body weight and height data from the authors.
KAM, knee adduction moment; BW, body weight; HT, height; q, quantitative; sq, semiquantitative grading; NA, non-applicable.
Figure 2 Forest plot of the
individual ORs of structural
disease progression with every
increment in baseline peak knee
adduction moment. Weights are
from a random effects analysis.
Individual and pooled estimates
are shown with 95% CIs.
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(baseline to 18 months) was associated with increased
KAM from 18 to 36 months.35 Thus, temporal correct-
ness cannot be assigned to the observed associations in
this study, and the overall Temporality criterion was not
satisﬁed (a 0 score). Biological Gradient was investigated
in one cohort29 that showed no positive association
between baseline peak KAM and loss of medial tibial
cartilage volume over 12 months, resulting in a score of
0. Consequently, the causation score based on the
included cohort studies was 0 for the association
between peak KAM during walking and structural
disease progression in patients with knee OA (table 3).
For the KAM impulse and overall knee compression
loading, only one study was available for each expos-
ure,29 33 and therefore no causation scores were calcu-
lated for these loading exposures.
As the systematic literature search did not identify any
RCTs, the ﬁndings from the cohort studies can neither
be conﬁrmed nor refuted by experimental evidence.
Hence, the ﬁfth criterion could not be used to upgrade
or downgrade the causation scores.
DISCUSSION
This review is the ﬁrst to systematically assess—using sys-
tematic review, meta-analysis, and the Bradford Hill con-
siderations on causality—whether a causal link exists
between knee joint loading during walking and struc-
tural disease progression of knee OA. The systematic lit-
erature search identiﬁed ﬁve prospective cohort studies
focusing on three estimates of knee joint loading: the
peak KAM, KAM impulse and overall tibiofemoral com-
pression force. Using a predeﬁned algorithm, a caus-
ation score of 0 was reached, showing that there is no
evidence of a causal link between knee joint loading
during walking and structural progression of knee OA.
Table 2 Summary of the quality assessment (risk of bias)
Bias
type Quality criteria
Miyazaki
et al30
Chang
et al31 35
Bennell
et al29
Woollard
et al32
Henriksen
et al33
Selection Were the descriptions of
the groups and the
distribution of prognostic
factors sufficient?
A I I A A
Were the groups
assembled at a similar
point in their disease
progression?
A I I A A
Were the groups
comparable on all
important confounding
factors?
I I I U A
Detection Was the joint load estimate
reliably ascertained?
U U U U I
Was adequate adjustment
made for the effects of
these confounding
variables?
A I A I I
Was outcome assessment
blind to exposure status?
A A I I A
Was follow-up long enough
for the outcomes to occur?
A A A A A
What proportion of the
cohort was followed-up?*
U A U A A
Attrition Were dropout rates and
reasons for drop-out
similar across groups?
I I I A A
Overall risk of bias† Very serious
limitations;
high risk of
bias
Very serious
limitations;
high risk of
bias
Very serious
limitations;
high risk of
bias
Very serious
limitations;
high risk of
bias
Very serious
limitations;
high risk of
bias
Methodological quality Low Low Low Low Low
*Adequate=follow-up proportion >80%; unclear 50–80%; inadequate=<50%.
†Risk of bias within studies is assessed using GRADE’s approach to study limitations: No serious limitation defined as all criteria being
adequately described (high methodological quality); serious limitations defined as one criterion being inadequately described or >1 criterion
being unclearly described (moderate methodological quality); very serious limitation defined as >1 criterion being inadequately described (low
methodological quality).
A, adequately described; I, inadequately described; U, unclear.
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Furthermore, no experimental data from RCTs exist to
support or oppose the ﬁndings from the cohort studies.
One of the prospective cohort studies33 compared
increased versus decreased loads, without demonstrating
differences in structural disease progression opposing a
causal link.
Indirectly supporting the current ﬁndings, a longitu-
dinal randomised trial comparing laterally wedged
insoles (previously demonstrated to reduce loading37 38)
with placebo insoles, showed no group differences in
structural disease progression.39 While that study seem-
ingly provided experimental evidence, no joint load
exposure data were included to document the assertion
that joint loadings were in fact reduced in the ‘wedged
insole’ group. Thus, the study did not fulﬁl the criteria
for inclusion in this review. A recent meta-analysis on
symptomatic effects of laterally wedged insoles showed
no beneﬁcial effects over neutral insoles, indicating
limited effects of laterally wedged insoles.40 However, the
null outcome is supported by the results in ref. 33,
included in this review, showing neither detrimental
effects of increased loading nor beneﬁcial effects of
decreased loading over 12 months in a group of knee
OA patients.
The quality assessment of the included studies showed
high risks of selection, detection and attrition biases
(table 3). An important precondition for valid results in
cohort studies is that groups should be comparable at
baseline. Unless the groups are balanced for relevant
baseline characteristics, differences in structural disease
progression cannot conﬁdently be attributed to the
effects of interest ( joint loads during walking). The
included studies revealed signiﬁcant inadequacies when
assessing the comparability of the groups on relevant
baseline characteristics, leading to prognostic imbalance.
Four of the ﬁve cohort studies did not report how reli-
ably the joint loading estimates were ascertained (detec-
tion bias), which could inﬂuence the individual results.
Moreover, the loss of subjects at follow-up in two of the
ﬁve cohort studies was beyond 20%, with the dropout
rates and reasons for dropout across groups not
adequately accounted for (attrition bias). Finally, the dis-
crepant numbers of subjects presented in different
reports from the same cohort31 35 introduced a serious
risk of bias and low conﬁdence in the results. The
overall low methodological quality of the included
studies gives little conﬁdence in the reported estimates
of causation.
Despite the shortage of studies reporting a causal link
between joint loading and structural disease progression,
the conjectured relationship underlies the rationale for
many clinical efforts to reduce knee loading during
walking in attempts to retard disease progression.
Weight loss, insoles, modiﬁed footwear, strengthening
exercises, knee braces and gait modiﬁcations have been
Figure 3 The mean baseline knee adduction moment (KAM)
knee joint load exposures in patients with and without
structural disease progression from the four individual cohorts.
Note the overlap between progressors and non-progressors in
the different studies. Error bars: 95% CI.
Table 3 Causation criteria and scores for the identified knee joint loading exposures
Knee joint load exposure
Strength*
Summary
or OR (95% CI)
Consistency†
N (%)
Temporality‡
N (%)
Biological
gradient§
N (%)
Causation score
(number of
criteria met)
Peak KAM 1.90 (0.85 to 4.25) 2/4 (50%) 1/4 (25%) 0/4 (0%) 0
KAM impulse 0.42 (0.12 to 1.48)¶ −** 0/1 (0%) 1/1 (100%) −††
Peak overall compression No group difference −** 1/1 (100%) 0/1 (0%) −††
*Strong association is defined as a pooled OR ≥5 with lower 95% CI excluding 2.0. Moderate association is any statistically significant
association.
†Consistency is defined as ≥75% of associations showing strong or moderate associations.
‡In cohort studies it is difficult if not impossible to ensure temporal correctness because participants in the studies are expected to walk
daily and are, therefore, exposed to knee joint loading throughout the observation period. In the current analysis, the temporality criterion is
satisfied in studies that relate baseline knee joint loading exposures to disease progression over time from that baseline and demonstrate a
statistically significant association with structural disease progression.
§Biological gradient is defined as demonstrated when the rate of progression increases (or decreases) incrementally as dose of exposure
increases.
¶Estimate based on one cohort study29 assessing baseline KAM impulse to progression of cartilage defects assessed by semiquantitative
grading of MRI.
**Consistency not possible to assess with only one cohort.
††Causality score not calculated because only one study available.
KAM, knee adduction moment.
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suggested as means to lower knee joint loads and thus
slow structural disease progression through mechanical
pathways,41–46 with effects yet to be proven. The ration-
ale for such efforts is diluted by the current results, not
only by the low causality score, but also by the inconsist-
ency across studies in the loading magnitudes between
individuals who progress and those that do not. Figure 3
illustrates that patients with a certain baseline peak KAM
magnitude in one study progress, whereas those with
similar baseline peak KAM magnitudes in other studies
do not. These differences in knee joint loading magni-
tudes between studies may be due to differences in gait
analysis protocols across the involved gait labs, for
example, in the selection of reference frame convention
for the calculation of the KAM47 and footwear condi-
tion.44 However, including diversity of measures of the
same variable can strengthen the conﬁdence in the
results of a systematic review.
The results from the included studies exhibited a high
degree of heterogeneity (I2 from the meta-analysis)
(ﬁgure 2). The two cohorts with signiﬁcant OR30 31 35
both used radiography as the structural outcome assess-
ment, whereas the studies reporting non-signiﬁcant ORs
used MRI.29 32 Furthermore, the two studies reporting
signiﬁcant associations had longer follow-up periods (72
and 18 months), whereas the studies without signiﬁcant
associations assessed disease progression after
12 months. This concurrence of follow-up time and
imaging modality precludes conclusions about whether
the differences in results are based on follow-up time or
imaging modality. Radiography is the current clinical
gold standard for assessing structural disease progres-
sion, but it has low temporal sensitivity, making long
follow-up times necessary. MRI—with its shorter tem-
poral sensitivity—is possibly the more promising tool for
assessing single structures and should be used in studies
with longer follow-up times. The total number of
patients was 452 in ﬁve cohorts; that is a very small
number of patients when considering the large popula-
tion and when compared to similar reviews in other
chronic diseases. For instance, a recent review of the
causal relationship between dietary factors and coronary
heart disease included several millions of individuals in
361 cohorts and a multitude of dietary exposures.23
Our study has strengths because we undertook several
measures to minimise bias, restricting our review to
studies with the strongest causal inference (cohort
studies and RCTs), conducted independent assessments
of study eligibility, and using predeﬁned criteria to evalu-
ate causation and methodological quality. We may be cri-
ticised for using arbitrary OR cut-offs to deﬁne strong
and moderate association, but identifying the true
cut-off for deﬁning clinically meaningful OR values is
impossible in a ﬁeld that has few longitudinal studies to
consult. An important limitation is the causality score
that applied. The score is a modiﬁcation of a previous
similar score,23 thus it has limited empirical evidence to
support its validity. Also, the causality score omitted
several of the original causation considerations as pro-
posed by Hill,21 yet the applied method was prespeci-
ﬁed. We may also be criticised for analysing any
image-based structural deterioration, rather than separ-
ating the analyses in X-ray and MRI-based assessments.
However, the analysis plans were also prespeciﬁed,
without prior knowledge of the number of studies and
speciﬁcs of the outcomes.
Current guidelines on interpretation of data from
observational studies and data combined from repeated
observational studies (with a reasonable internal validity)
would correspond to conﬁdence in the estimate’s being
‘Low-quality evidence’, but could be upgraded if there is
great conﬁdence in the estimates and the effects are
large.48 However, the current analysis revealed a large
inconsistency among study results, poor precision of the
combined analysis, and low methodological quality.
Thus, we downgraded further to ‘very low quality evi-
dence’. The inconsistency of the available studies may
limit the appropriateness of meta-analyses, yet support
the overall conclusion of this systematic literature review.
In conclusion, our systematic review, meta-analyses,
and application of Bradford Hill’s considerations on
causation shows that there is no evidence of a causal link
between estimates of knee joint loading during walking
and structural progression of knee OA. Future large well-
designed prospective cohorts with subsequent conﬁrm-
ation from randomised trials are strongly recommended.
The current study ﬁndings question the rationale
behind clinical efforts to reduce knee joint loading
during walking as such efforts are currently supported
by very low-quality evidence showing no causal link
between knee joint loading during walking and progres-
sion of knee OA.
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